Skip to main content
. 2024 Mar 26;25(7):3695. doi: 10.3390/ijms25073695

Table 3.

Mean VAF according to cancer-specific survival (CSS).

Pre-Treatment VAF Post-Treatment VAF p-Value
Cancer-specific death
TERT c.-124C>T 159% 34% 0.09
TERT c.-146C>T 8% 0% 0.23
ATM c.1236-2A>T 1% 1% 0.55
TP53 c.853G>A 83% 8% 0.11
Remaining patients
TERT c.-124C>T 12% 7% 0.15
TERT c.-146C>T 16% 9% 0.33
ATM c.1236-2A>T 5% 5% 0.41
TP53 c.853G>A 73% 81% 0.20